Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized Placebo-controlled Trial of Vasopressin Treatment for Social Deficits in Children With Autism

NCT01962870 is registered in ClinicalTrials.gov with Stanford University as lead sponsor.

NCT NCT01962870
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01962870 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized Placebo-controlled Trial of Vasopressin Treatment for Social Deficits in Children With Autism
Lead sponsor
Stanford University
Phase
Phase 2
Overall status
Completed
Start date
December 31, 2013
Completion date
May 30, 2017
Enrollment
68 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

autism spectrum disorders